8th Annual Pharma CI Europe Conference & Exhibition. Basel, Switzerland. March 5-6, 2019
The 8th Annual Pharma CI Europe Conference (March 5-6, 2019, Basel, Switzerland) is the best and largest assembly of competitive intelligence executives in pharma, biotech, and medical devices! This anticipated gathering of industry elites will feature a program agenda led by a celebrated speaking faculty comprising 30+ pharma, biotech companies, about 50% of which are new to the conference.
The Pharma CI Europe Conference will feature the involvement of the industry’s most prominent companies, such as: Abbott Established Pharmaceuticals, Acino International, Actelion, Aimmune Therapeutics, Atacana Group, Bayer, Boehringer Ingelheim, Cambridge Healthcare
Research, Celgene, Chiesi Farmaceutici S.p.A., Course5, Deallus, Debiopharm S.A., Dig Worldwide, Digimind, dtw Research, Elanco, Evaluate, FirstWord, Fletcher/CSI, Fresenius Kabi, GlaxoSmithKline, GW Pharmaceuticals, Helsinn Healthcare, Hovione, IBM Watson Health, INOVIS, Ipsen, Jazz Pharmaceuticals, Johnson & Johnson Family of Companies, Leo Pharma, Lifescience Dynamics, Lonza, Merck kGaA, Merz, Molekule Consulting, Mundipharma, Novartis Pharma AG, Novo Nordisk A/S, Osprey Health Consulting, PharmaForce International, Prescient Healthcare Group, Proactive Worldwide, RAS LSS Consulting, SAI MedPartners, Sandoz, Sanofi, Santen, Servier, SOTIO, a.s., Springer Nature, Takeda, TESARO, UCB, Unither Pharmaceuticals, Vifor Pharma, Voxx Analytics, and many more.
You’ll also hear from speakers from the most accomplished agencies and service providers. Each year this program agenda focuses on trending topics, industry innovations and both international and regional perspectives.
Find out what insiders already know: the Pharma CI Conference is the best and largest conference series for competitive intelligence executives in pharma, biotech, and medical devices for 10+ Years. You’ll see why this premier event is always the most talked-about and well-attended conference in the industry.